Accueil › Obésité › Pennsylvanie › Pittsburgh
Essais cliniques pour Obésité à Pittsburgh, PA
13 études pour Obésité recherchent des participants dans et autour de Pittsburgh (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Recrutement en coursPhase 3
- Heritage Valley Medical Group, Beaver · à 24 mi
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Recrutement en coursPhase 3
- UPMC Child Hosp-Pittsburgh, Pittsburgh
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Recrutement en coursPhase 3
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Recrutement en coursPhase 3
- Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair, Pittsburgh
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Recrutement en coursPhase 3
- Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18), Pittsburgh
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Recrutement en coursPhase 3
- Heritage Valley Multispecialty Group Inc, Beaver · à 24 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Recrutement en coursPhase 3
- AURORA-2 Clinical Site, Pittsburgh
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Recrutement en coursPhase 3
- University of Pittsburgh Medical Center, Pittsburgh
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Recrutement en coursPhase 3
- VA Pittsburgh Healthcare System, Pittsburgh
Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Complete a Weight Loss Program, Half Get Scales at Baseline, Half at Month 6 Those Who Receive the Bed Scales at Baseline Are Expected to Have Increased Weight Loss
Recrutement en cours
- University of Pittsburgh, Bakery Square, Department of Rehabilitation Science and Technology, Pittsburgh
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Recrutement en cours
- University of Pittsburgh, Pittsburgh
The Effects of Strength Training on Muscle Mass and Mental Health in Adults Taking Obesity Medication
Recrutement en cours
- Physical Activity Research Center, University of Pittsburgh, Pittsburgh
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Essais pour Obésité dans d'autres villes
- Houston, TX43 études
- Chicago, IL41 études
- New York City, NY40 études
- San Antonio, TX40 études
- Washington, DC33 études
- Orlando, FL31 études
- Dallas, TX30 études
- Boston, MA28 études
- Las Vegas, NV27 études
- Miami, FL27 études
- Baltimore, MD25 études
- Jacksonville, FL25 études
Autres études à Pittsburgh
- Cancer du poumon non à petites cellules48 études
- Cancer (tous types)41 études
- Cancer du sein39 études
- Cancer colorectal32 études
- Cancer métastatique31 études
- Mélanome31 études
- Cancer de l'ovaire30 études
- Cancer de l'endomètre23 études
- Cancer du poumon23 études
- Cancer de la prostate23 études
- Accident vasculaire cérébral22 études
- Carcinome épidermoïde de la tête et du cou22 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.